ArticleDrug design, development and therapy2020

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia.

Jason D Lickliter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.